Procurement of storage and stability services to maintain BARDA’s supply of Live Attenuated Influenza Virus Master and Working Seed Lots

Award Notice Posted

Solicitation number
75A50125P00002
Agency
Awarded
to Medimmune LLC
Set-aside
No set-aside

Opportunity facts

Contract number
75A50125P00002 Federal contract award
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
6505 Drugs And Biologicals
Place of performance
Gaithersburg, Maryland 20878, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, has awarded a Firm Fixed Price sole source purchase order to MedImmune, LLC for storage and stability services related to Live Attenuated Influenza Virus Master and Working Seed Lots. The contract, valued at $84,014.04, was awarded on March 13, 2025, under a previously established indefinite-delivery, indefinite-quantity (ID/IQ) contract from 2016 for Medical Countermeasures for Pandemic Influenza. MedImmune was selected as the sole source provider per FAR 6.3021, as they have been continuously performing storage and stability testing of these seed lots, which are critical for producing clinical trial material and commercial-scale drug substances for pandemic preparedness. The awarded contract (75A50125P00002) ensures continued maintenance and testing of these seed lots to maintain their specifications for potential future vaccine production.

Notice text

Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) awarded a Firm Fixed Price sole source purchase order with Medimmune, LLC, located at One Medimmune Way, Gaithersburg, Maryland 20878-4028 for the procurement of storage and stability services to maintain BARDA’s supply of Live Attenuated Influenza Virus Master and Working Seed Lots.

The government awarded a sole source purchase order to MedImmune, LLC., per FAR 6.302‑1, as no other source would satisfy agency requirements.  MedImmune was awarded an indefinite-delivery, indefinite-quantity (ID/IQ) contract for the acquisition of Medical Countermeasures (MCMs) for Pandemic Influenza in 2016.  Under that contract, task orders were issued to produce cGMP Influenza Vaccine Master and Working Seed Lots, including storage and stability testing of the seed lots.  Since the IDIQ award, MedImmune has been performing storage and stability testing of the Live Attenuated Master and Working Seed Lots. The seed lots are used for the production of clinical trial material or commercial-scale drug substances for pandemic preparedness. Storage and stability testing of the seed lots is required to ensure they remain within the specification of this requirement.

Awarded contract 75A50125P00002 to MEDIMMUNE LLC for 84014.04 on 2025-03-13.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors